Hepatitis B Virus-Related Cryoglobulinemic Vasculitis: Review of the Literature and Long-Term Follow-Up Analysis of 18 Patients Treated with Nucleos(t)ide Analogues from the Italian Study Group of Cryoglobulinemia (GISC)

Overview

Journal Viruses

Publisher MDPI

Specialty Microbiology

Date 2021 Jun 2

PMID 34070832

Citations 7

Authors

Cesare Mazzaro

Luigino Dal Maso

Laura Gragnani

Marcella Visentini

Francesco Saccardo

Davide Filippini

Pietro Andreone

Anna Linda Zignego

Valter Gattei

Giuseppe Monti

Massimo Galli

Luca Quartuccio

Affiliations

Soon will be listed here.

Abstract

Hepatitis B virus (HBV) chronic infection causes progressive liver damage, although about 20% of patients develop extrahepatic manifestations such as cryoglobulinemic vasculitis (CV). Clinical manifestations range from mild to moderate (purpura, asthenia, arthralgia) to severe (leg ulcers, peripheral neuropathy, glomerulonephritis, non-Hodgkin lymphoma). A comprehensive review of therapeutic options for HBV-related CV is lacking. Nucleos(t)ide analogues (NA) suppress HBV replication in 90-100% of cases and induce clinical response in most patients with mild-to-moderate CV. Plasma exchange can be performed in patients with severe CV and should be considered in severe or life-threatening cases combined with high doses of corticosteroids and antiviral treatment. A cautious use of rituximab can be considered only in association with NA treatment in refractory cases. A review of the literature and an analysis of data collected by six centers of the Italian Group for the Study of Cryoglobulinemia on 18 HBV-CV nucleotide/nucleoside analogues (NAs)-treated patients were carried out.

Citing Articles

Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis B Virus Infections.

Songtanin B, Chaisrimaneepan N, Mendoza R, Nugent K Viruses. 2024; 16(4).

PMID: 38675959 PMC: 11055091. DOI: 10.3390/v16040618.

High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy.

Visentini M, Pica A, DIppolito G, Sculco E, La Gualana F, Gragnani L Ann Hematol. 2023; 102(12):3457-3463.

PMID: 37650886 PMC: 10640471. DOI: 10.1007/s00277-023-05412-1.

New-onset systemic vasculitis following SARS-CoV-2 infection and vaccination: the trigger, phenotype, and outcome.

Mv P, Auanassova A, Yessirkepov M, Zimba O, Gasparyan A, Kitas G Clin Rheumatol. 2023; 42(10):2761-2775.

PMID: 37422611 DOI: 10.1007/s10067-023-06694-6.

Hepatitis B virus-infection related cryoglobulinemic vasculitis. Clinical manifestations and the effect of antiviral therapy: A review of the literature.

Mazzaro C, Bomben R, Visentini M, Gragnani L, Quartuccio L, Saccardo F Front Oncol. 2023; 13:1095780.

PMID: 36824142 PMC: 9941626. DOI: 10.3389/fonc.2023.1095780.

Extrahepatic Manifestations of Chronic HBV Infection and the Role of Antiviral Therapy.

Mazzaro C, Adinolfi L, Pozzato G, Nevola R, Zanier A, Serraino D J Clin Med. 2022; 11(21).

PMID: 36362478 PMC: 9657147. DOI: 10.3390/jcm11216247.

References

Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E . Association between hepatitis C virus and mixed cryoglobulinemia [see comment]. Clin Exp Rheumatol. 1991; 9(6):621-4. View

Ferri C, Sebastiani M, Giuggioli D, Cazzato M, Longombardo G, Antonelli A . Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum. 2004; 33(6):355-74. DOI: 10.1016/j.semarthrit.2003.10.001. View

Ferri C, Moriconi L, Gremignai G, Migliorini P, Paleologo G, FOSELLA P . Treatment of the renal involvement in mixed cryoglobulinemia with prolonged plasma exchange. Nephron. 1986; 43(4):246-53. DOI: 10.1159/000183849. View

Zignego A, Ramos-Casals M, Ferri C, Saadoun D, Arcaini L, Roccatello D . International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement. Autoimmun Rev. 2017; 16(5):523-541. DOI: 10.1016/j.autrev.2017.03.004. View

De Vita S, Quartuccio L, Salvin S, Corazza L, Zabotti A, Fabris M . Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy. Rheumatology (Oxford). 2012; 51(4):627-33. DOI: 10.1093/rheumatology/ker407. View

Agnello V, Chung R, Kaplan L . A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med. 1992; 327(21):1490-5. DOI: 10.1056/NEJM199211193272104. View

Roccatello D, Fornasieri A, Giachino O, Rossi D, Beltrame A, Banfi G . Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis. Am J Kidney Dis. 2006; 49(1):69-82. DOI: 10.1053/j.ajkd.2006.09.015. View

Vigano M, Martin P, Cappelletti M, Fabrizi F . HBV-associated cryoglobulinemic vasculitis: remission after antiviral therapy with entecavir. Kidney Blood Press Res. 2014; 39(1):65-73. DOI: 10.1159/000355778. View

Vacchi C, Visentini M, Gragnani L, Fraticelli P, Tavoni A, Filippini D . Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar). Intern Emerg Med. 2020; 16(1):149-156. DOI: 10.1007/s11739-020-02386-0. View

10.

Terrier B, Marie I, Lacraz A, Belenotti P, Bonnet F, Chiche L . Non HCV-related infectious cryoglobulinemia vasculitis: Results from the French nationwide CryoVas survey and systematic review of the literature. J Autoimmun. 2015; 65:74-81. DOI: 10.1016/j.jaut.2015.08.008. View

11.

Retamozo S, Gheitasi H, Quartuccio L, Kostov B, Corazza L, Bove A . Cryoglobulinaemic vasculitis at diagnosis predicts mortality in primary Sjögren syndrome: analysis of 515 patients. Rheumatology (Oxford). 2016; 55(8):1443-51. DOI: 10.1093/rheumatology/kew194. View

12.

Visentini M, Pascolini S, Mitrevski M, Marrapodi R, Del Padre M, Todi L . Hepatitis B virus causes mixed cryoglobulinaemia by driving clonal expansion of innate B-cells producing a VH1-69-encoded antibody. Clin Exp Rheumatol. 2016; 34(3 Suppl 97):S28-32. View

13.

Monti G, Galli M, Invernizzi F, Pioltelli P, Saccardo F, Monteverde A . Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias. QJM. 1995; 88(2):115-26. View

14.

Gorevic P, Frangione B . Mixed cryoglobulinemia cross-reactive idiotypes: implications for the relationship of MC to rheumatic and lymphoproliferative diseases. Semin Hematol. 1991; 28(2):79-94. View

15.

Kawakami T, Ooka S, Mizoguchi M, Soma Y, Yamazaki M . Remission of hepatitis B virus-related cryoglobulinemic vasculitis with entecavir. Ann Intern Med. 2008; 149(12):911-2. DOI: 10.7326/0003-4819-149-12-200812160-00018. View

16.

Stefanutti C, Vivenzio A, Di Giacomo S, Labbadia G, Mazza F, DAlessandri G . Immunoadsorption apheresis and immunosuppressive drug therapy in the treatment of complicated HCV-related cryoglobulinemia. J Clin Apher. 2009; 24(6):241-6. DOI: 10.1002/jca.20222. View

17.

Cacoub P, Hausfater P, Musset L, Piette J . Mixed cryoglobulinemia in hepatitis C patients. GERMIVIC. Ann Med Interne (Paris). 2000; 151(1):20-9. View

18.

Pozzato G, Mazzaro C, Gattei V . Hepatitis C Virus-Associated Non-Hodgkin Lymphomas: Biology, Epidemiology, and Treatment. Clin Liver Dis. 2017; 21(3):499-515. DOI: 10.1016/j.cld.2017.03.006. View

19.

Ramos-Casals M, Stone J, Cid M, Bosch X . The cryoglobulinaemias. Lancet. 2011; 379(9813):348-60. DOI: 10.1016/S0140-6736(11)60242-0. View

20.

Cacoub P, Terrier B . Hepatitis B-related autoimmune manifestations. Rheum Dis Clin North Am. 2009; 35(1):125-37. DOI: 10.1016/j.rdc.2009.03.006. View